- Tytuł:
- Cost-Effectiveness Analysis of Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China
- Autorzy:
- Temat:
-
esophageal squamous cell carcinoma
cost-effectiveness
partitioned survival model
tislelizumab
Public aspects of medicine
RA1-1270 - Źródło:
- Risk Management and Healthcare Policy, Vol Volume 16, Pp 2447-2458 (2023)
- Opis pliku:
- electronic resource
- Relacje:
- https://www.dovepress.com/cost-effectiveness-analysis-of-tislelizumab-plus-chemotherapy-as-first-peer-reviewed-fulltext-article-RMHP; https://doaj.org/toc/1179-1594
- Dostęp URL:
- https://doaj.org/article/a9167dc09d9f482c8e7b07eb8cde4a62  Link otwiera się w nowym oknie
Czasopismo naukowe